Published in Future Oncol on October 01, 2012
Tumor glycolysis as a target for cancer therapy: progress and prospects. Mol Cancer (2013) 1.57
Dietary restriction-resistant human tumors harboring the PIK3CA-activating mutation H1047R are sensitive to metformin. Oncotarget (2013) 1.01
Chemical inhibition of acetyl-CoA carboxylase suppresses self-renewal growth of cancer stem cells. Oncotarget (2014) 0.81
Malignancy-associated metabolic profiling of human glioma cell lines using 1H NMR spectroscopy. Mol Cancer (2014) 0.79
Targeting tumour energy metabolism potentiates the cytotoxicity of 5-aminolevulinic acid photodynamic therapy. Br J Cancer (2013) 0.79
Chronic Myeloid Leukemia and Hepatoblastoma: Two Cancer Models to Link Metabolism to Stem Cells. Front Oncol (2016) 0.78
Metabolomic profiling predicts outcome of rituximab therapy in rheumatoid arthritis. RMD Open (2016) 0.75
CYP1B1 mutations in French patients with early-onset primary open-angle glaucoma. J Med Genet (2004) 1.59
Human ATP synthase beta is phosphorylated at multiple sites and shows abnormal phosphorylation at specific sites in insulin-resistant muscle. Diabetologia (2009) 0.98
Applications of tritium NMR to macromolecules: a study of two nucleic acid molecules. J Biomol NMR (1996) 0.76
Chromatographic, NMR and vibrational spectroscopic investigations of astaxanthin esters: application to "Astaxanthin-rich shrimp oil" obtained from processing of Nordic shrimps. Analyst (2015) 0.75
Laser beam diffraction at the edge of a film and application to thin film metrology. Appl Opt (2013) 0.75